0000000000123725

AUTHOR

Eva Gamper

showing 3 related works from this author

Following patient pathways to psycho-oncological treatment: Identification of treatment needs by clinical staff and electronic screening.

2017

OBJECTIVE In this retrospective investigation of patient pathways to psycho-oncological treatment (POT), we compared the number of POT referrals before and after implementation of electronic screening for POT needs and investigated psychosocial predictors for POT wish at a nuclear medicine department. METHODS We extracted medical chart information about number of referrals and extent of follow-up contacts. During standard referral (November 2014 to October 2015), POT needs were identified by clinical staff only. In the screening-assisted referral period (November 2015 to October 2016), identification was supported by electronic screening for POT needs. Psychosocial predictors for POT wish w…

AdultMalemedicine.medical_specialtyReferralPsycho-OncologyPsycho-oncologyExperimental and Cognitive PsychologyAnxietyLogistic regression03 medical and health sciences0302 clinical medicinemedicineHumansMass Screening030212 general & internal medicineReferral and ConsultationMass screeningAgedRetrospective Studiesbusiness.industryMedical recordfungitechnology industry and agriculturefood and beveragesRetrospective cohort studyMiddle AgedPatient Acceptance of Health CarehumanitiesPsychiatry and Mental healthNeuroendocrine TumorsOncology030220 oncology & carcinogenesisFamily medicineAnxietyFemalemedicine.symptombusinessPsychosocialStress PsychologicalPsycho-oncology
researchProduct

Quality of Life in Patients With Hypoparathyroidism After Treatment for Thyroid Cancer.

2020

Abstract Purpose Surgical complications such as hypoparathyroidism (HPT) or vocal cord palsy are seldom assessed when the quality of life (QOL) in thyroid cancer patients is investigated. The aim of this study was to measure the QOL difference in thyroid cancer survivors with and without HPT. Methods Participants for this analysis were enrolled in 13 countries from a study that pilot-tested a thyroid cancer–specific QOL instrument. They were included if they had been diagnosed with thyroid cancer at least 9 months previously. QOL was measured using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core (EORTC QLQ-C30) and some items on HPT symptoms…

AdultMalemedicine.medical_specialtyHypoparathyroidismEndocrinology Diabetes and MetabolismHealth StatusClinical BiochemistryPilot ProjectsBiochemistryEndocrinologyPostoperative ComplicationsQuality of lifeCancer SurvivorsInternal medicineSurveys and QuestionnairesMedicineHumansIn patientThyroid NeoplasmsThyroid cancerAgedbusiness.industryBiochemistry (medical)ThyroidCancerMiddle Agedmedicine.diseasehumanitiesmedicine.anatomical_structureEndocrinologyCross-Sectional StudiesHypoparathyroidismMann–Whitney U testQuality of LifeFemalebusinessAfter treatmentThe Journal of clinical endocrinology and metabolism
researchProduct

Quality-of-Life Priorities in Patients with Thyroid Cancer : a Multinational European Organisation for Research and Treatment of Cancer Phase I Study

2016

Item does not contain fulltext BACKGROUND: The objectives of this study were to determine quality of life (QoL) issues that are relevant to thyroid cancer patients cross-culturally, and to identify those with highest relevance to them in addition to the more general issues covered by the core European Organisation for Research and Treatment of Cancer QoL questionnaire (EORTC QLQ-C30). METHODS: A systematic literature search provided a list of potentially relevant QoL issues to supplement the core questionnaire EORTC QLQ-C30, which is widely used in research and in care and addresses QoL issues relevant to all groups of cancer patients. A panel of experts revised this list, and thyroid cance…

AdultCross-Cultural ComparisonMalemedicine.medical_specialtyPathologyInternationalityEndocrinology Diabetes and MetabolismAlternative medicine030209 endocrinology & metabolism03 medical and health sciences0302 clinical medicineEndocrinologyQuality of lifeAdenocarcinoma FollicularMedicineHumansIn patientThyroid NeoplasmsVoluntary Health AgenciesThyroid cancerFatigueAgedNeoplasm StagingAged 80 and overbusiness.industryCancerRehabilitation VocationalMiddle Agedmedicine.diseaseCross-cultural studiesCombined Modality TherapyCarcinoma PapillaryhumanitiesPhase i studyCarcinoma NeuroendocrineEuropeMultinational corporationThyroid Cancer Papillary030220 oncology & carcinogenesisFamily medicineCarcinoma MedullaryQuality of LifeFemaleSelf ReportbusinessRare cancers Radboud Institute for Health Sciences [Radboudumc 9]
researchProduct